Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254580080> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4254580080 endingPage "1277" @default.
- W4254580080 startingPage "1273" @default.
- W4254580080 abstract "Context.—Nonvalvular atrial fibrillation (AF) carries an increased risk for stroke, but absolute rates of stroke vary widely within the broad spectrum of AF patients.Objective.—To prospectively validate a risk stratification scheme identifying patients with AF with low rates of stroke when given aspirin.Design.—Prospective cohort study with mean duration of follow-up of 2.0 years, conducted between 1993 and 1997.Setting.—Outpatient clinics affiliated with academic medical centers.Patients.—Patients with AF categorized as low risk based on the absence of 4 prespecified thromboembolic risk factors: recent congestive heart failure or left ventricular fractional shortening of 25% or less, previous thromboembolism, systolic blood pressure greater than 160 mm Hg, or female sex at age older than 75 years.Intervention.—All participants given aspirin, 325 mg/d.Main Outcome Measures.—Ischemic stroke (considered disabling when Rankin score was II or worse 1-3 months later) and systemic embolism (primary events).Results.—Among 892 participants, the mean (SD) age was 67 (10) years, 78% were men, and histories of hypertension, diabetes, and ischemic heart disease were present in 46%, 13%, and 16%, respectively. The rate of primary events was 2.2% per year (95% confidence interval [CI], 1.6%-3.0%), of ischemic stroke was 2.0% per year (95% CI, 1.5%-2.8%), and of disabling ischemic strokes was 0.8% per year (95% CI, 0.5%-1.3%). Those with a history of hypertension had a higher rate of primary events (3.6% per year) than those with no history of hypertension (1.1% per year) (P<.001). The rate of disabling ischemic stroke was low in those with and without a history of hypertension (1.4% per year and 0.5% per year, respectively). The rate of major bleeding during aspirin therapy was 0.5% per year.Conclusion.—Patients with AF who have relatively low rates of ischemic stroke, particularly disabling stroke, during treatment with aspirin can be reliably identified." @default.
- W4254580080 created "2022-05-12" @default.
- W4254580080 creator A5053449503 @default.
- W4254580080 date "1998-04-22" @default.
- W4254580080 modified "2023-10-17" @default.
- W4254580080 title "Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study" @default.
- W4254580080 doi "https://doi.org/10.1001/jama.279.16.1273" @default.
- W4254580080 hasPublicationYear "1998" @default.
- W4254580080 type Work @default.
- W4254580080 citedByCount "250" @default.
- W4254580080 countsByYear W42545800802012 @default.
- W4254580080 countsByYear W42545800802013 @default.
- W4254580080 countsByYear W42545800802014 @default.
- W4254580080 countsByYear W42545800802015 @default.
- W4254580080 countsByYear W42545800802016 @default.
- W4254580080 countsByYear W42545800802017 @default.
- W4254580080 countsByYear W42545800802018 @default.
- W4254580080 countsByYear W42545800802019 @default.
- W4254580080 countsByYear W42545800802020 @default.
- W4254580080 countsByYear W42545800802021 @default.
- W4254580080 countsByYear W42545800802022 @default.
- W4254580080 countsByYear W42545800802023 @default.
- W4254580080 crossrefType "journal-article" @default.
- W4254580080 hasAuthorship W4254580080A5053449503 @default.
- W4254580080 hasBestOaLocation W42545800801 @default.
- W4254580080 hasConcept C126322002 @default.
- W4254580080 hasConcept C127413603 @default.
- W4254580080 hasConcept C134018914 @default.
- W4254580080 hasConcept C151730666 @default.
- W4254580080 hasConcept C164705383 @default.
- W4254580080 hasConcept C188816634 @default.
- W4254580080 hasConcept C2777628954 @default.
- W4254580080 hasConcept C2778198053 @default.
- W4254580080 hasConcept C2779161974 @default.
- W4254580080 hasConcept C2779343474 @default.
- W4254580080 hasConcept C2780645631 @default.
- W4254580080 hasConcept C555293320 @default.
- W4254580080 hasConcept C71924100 @default.
- W4254580080 hasConcept C78519656 @default.
- W4254580080 hasConcept C86803240 @default.
- W4254580080 hasConceptScore W4254580080C126322002 @default.
- W4254580080 hasConceptScore W4254580080C127413603 @default.
- W4254580080 hasConceptScore W4254580080C134018914 @default.
- W4254580080 hasConceptScore W4254580080C151730666 @default.
- W4254580080 hasConceptScore W4254580080C164705383 @default.
- W4254580080 hasConceptScore W4254580080C188816634 @default.
- W4254580080 hasConceptScore W4254580080C2777628954 @default.
- W4254580080 hasConceptScore W4254580080C2778198053 @default.
- W4254580080 hasConceptScore W4254580080C2779161974 @default.
- W4254580080 hasConceptScore W4254580080C2779343474 @default.
- W4254580080 hasConceptScore W4254580080C2780645631 @default.
- W4254580080 hasConceptScore W4254580080C555293320 @default.
- W4254580080 hasConceptScore W4254580080C71924100 @default.
- W4254580080 hasConceptScore W4254580080C78519656 @default.
- W4254580080 hasConceptScore W4254580080C86803240 @default.
- W4254580080 hasIssue "16" @default.
- W4254580080 hasLocation W42545800801 @default.
- W4254580080 hasOpenAccess W4254580080 @default.
- W4254580080 hasPrimaryLocation W42545800801 @default.
- W4254580080 hasRelatedWork W1986780333 @default.
- W4254580080 hasRelatedWork W2058741266 @default.
- W4254580080 hasRelatedWork W2067977631 @default.
- W4254580080 hasRelatedWork W2073453392 @default.
- W4254580080 hasRelatedWork W2115859112 @default.
- W4254580080 hasRelatedWork W2348720246 @default.
- W4254580080 hasRelatedWork W2501441795 @default.
- W4254580080 hasRelatedWork W2742831078 @default.
- W4254580080 hasRelatedWork W2769154740 @default.
- W4254580080 hasRelatedWork W2917172139 @default.
- W4254580080 hasVolume "279" @default.
- W4254580080 isParatext "false" @default.
- W4254580080 isRetracted "false" @default.
- W4254580080 workType "article" @default.